Rahil J, Pratt R F
Department of Chemistry, Wesleyan University, Middletown, Connecticut 06459.
Biochemistry. 1992 Jun 30;31(25):5869-78. doi: 10.1021/bi00140a024.
The class C serine beta-lactamase of Enterobacter cloacae P99 was inhibited by a series of aryl methylphosphonate monoester monoanions. The effectiveness of these inhibitors was promoted by an acylamido substituent on the methyl group and a good leaving group at phosphorus. The former preference suggests that noncovalent interaction of these inhibitors with the enzyme resembles that of substrates, while the latter suggests that nucleophilic displacement at phosphorus occurs as part of the inhibition mechanism. The truth of the latter proposition was confirmed by observation of release of 1 equiv of phenol concomitant with inhibition and of the presence of an equivalent amount of 14C-label on the enzyme after inhibition by a 14C-labeled phosphonate. The hydrolytically inert nature of the enzyme-inhibitor adduct, and its 31P chemical shift, suggested that O-phosphonylation of the enzyme had occurred. Although, by analogy with substrates, one might expect that the hydroxyl of the active site serine residue would be covalently modified by these inhibitors, successive alkali and acid treatment of the enzyme-inhibitor adduct generated no pyruvate. Instead, 1 equiv of lysinoalanine was found. This product was rationalized to arise through intramolecular capture by an adjacent lysine amine group of the dehydroalanine residue produced by alkali treatment of an O-phosphonylated serine residue. One equivalent of lysinoalanine was also produced by alkali treatment of the enzyme that had been inhibited by 6 beta-bromopenicillanic acid, a mechanism-based inhibitor known to acylate the hydroxyl group of the active site serine residue. It is therefore likely that the aryl phosphonates phosphonylate this residue. These compounds should be useful as beta-lactamase active site titrants and as sources of fresh insight into the chemical properties of the active site. The significant mechanistic features of the inhibition, in particular its strong leaving group dependence and the distinctive ability of the beta-lactamase active site to stabilize a dianionic transition state containing a pentacoordinated phosphorus, are discussed with respect to the active site structure. The comparison with phosph(or/on)yl inhibitors of serine proteinases is made, and the mechanism-based features of inhibition of serine hydrolases by phosph(on)ates are noted.
阴沟肠杆菌P99的C类丝氨酸β-内酰胺酶受到一系列芳基甲基膦酸单酯单阴离子的抑制。这些抑制剂的有效性因甲基上的酰氨基取代基和磷原子上的良好离去基团而增强。前者的偏好表明这些抑制剂与酶的非共价相互作用类似于底物,而后者表明磷原子上的亲核取代是抑制机制的一部分。通过观察到抑制时伴随释放1当量苯酚以及用14C标记的膦酸酯抑制后酶上存在等量的14C标记,证实了后一命题的真实性。酶-抑制剂加合物的水解惰性及其31P化学位移表明酶发生了O-膦酰化。尽管根据与底物的类比,人们可能预期这些抑制剂会共价修饰活性位点丝氨酸残基的羟基,但对酶-抑制剂加合物进行连续的碱处理和酸处理未产生丙酮酸。相反,发现了1当量的赖氨酸丙氨酸。该产物被认为是由碱处理O-膦酰化丝氨酸残基产生的脱氢丙氨酸残基被相邻的赖氨酸胺基团分子内捕获而产生的。用6β-溴青霉烷酸抑制后的酶经碱处理也产生1当量的赖氨酸丙氨酸,6β-溴青霉烷酸是一种已知会酰化活性位点丝氨酸残基羟基的基于机制的抑制剂。因此,芳基膦酸酯很可能使该残基膦酰化。这些化合物可用作β-内酰胺酶活性位点滴定剂,并有助于深入了解活性位点的化学性质。结合活性位点结构讨论了抑制作用的重要机制特征,特别是其对离去基团的强烈依赖性以及β-内酰胺酶活性位点稳定含五配位磷的双阴离子过渡态的独特能力。还与丝氨酸蛋白酶的膦(酰)基抑制剂进行了比较,并指出了膦(酸)酯对丝氨酸水解酶抑制作用的基于机制的特征。